Business Context and Reporting Period
This Form 8-K Current Report from Inogen, Inc. (INGN) covers events occurring on January 30, 2025, and January 31, 2025, with the report filed on February 3, 2025. The filing addresses changes to the Company's Board of Directors, specifically the resignation of one director and the appointment of another.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance changes and director compensation arrangements.
Material Changes
- Resignation of Director: Thomas A. West resigned from the Board of Directors, the Compliance Committee, and the Nominating and Governance Committee effective January 30, 2025. The resignation is not the result of any disagreement with the Company regarding operations, policies, or practices.
- Appointment of Director: Mira Kirti Sahney was appointed to the Board effective January 31, 2025, serving as a Class III director with a term expiring in 2026. She was also appointed to the Nominating and Governance Committee and the Compliance Committee.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It details the background of the new director, Ms. Sahney, noting her previous roles as President of the Pelvic Health Operating Unit at Medtronic plc and CEO of Hyalex Orthopaedics. It also outlines her compensation package:
- Cash Fees: $45,000 annually for Board service, plus $5,000 annually for each committee membership (Nominating and Governance; Compliance), paid quarterly in arrears.
- Equity Award: An initial grant of 9,112 restricted stock units (RSUs) vesting on May 14, 2025, contingent on continued service.
Investor Verification Checklist
- Verify the effective dates of the director resignation and appointment (January 30 and 31, 2025).
- Confirm the vesting schedule and quantity of the RSU award granted to the new director (9,112 units vesting May 14, 2025).
- Review the press release referenced as Exhibit 99.1 for additional context on the appointment.
- Note that no financial results or operational updates are included in this specific filing.